$CENTA

Central Garden & Pet (NASDAQ:CENT) reported Q3 organic sales growth and margin expansion. Pet sales fell 19% to $400M due to a distribution exit, while organic pet sales rose 2% to $380M. Pet non-GAAP operating income fell 2% to $76M; margin rose 320 bps to 19%. Garden sales rose 3% to $482M; margin improved 70 bps to 18.9%. Central agreed to buy 80% of TRIXIE for €340M plus up to €60M earn-out.

Central Garden & Pet (NASDAQ: CENT) reported Q2 CY2026 results. Revenue fell 8.2% year on year to $882.4 million but beat market estimates by 0.6%, while non-GAAP EPS of $1.54 matched consensus. Free cash flow was $327 million with a 37.1% margin. The article says full-year EPS guidance missed and the stock was flat at $44.06.

CENTRAL GARDEN & PET CO (CENT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q32026pressrelease.htm EX-99.1 Document Exhibit 99.1 CENTRAL GARDEN & PET ANNOUNCES Q3 FISCAL 2026 FINANCIAL RESULTS Reports fiscal 2026 Q3 net sales decline of 8%, with organic sales growth of 2% Delivers fiscal 2026 Q3 GAAP diluted EPS of $1.45 versus $1.52 in the pri

Central Garden & Pet (NASDAQ: CENT) is set to report Q2 results Wednesday afternoon. The company previously beat revenue expectations with $906.2 million revenue, up 8.7% year on year. For the upcoming quarter, analysts expect revenue to fall 8.8% year on year. CENT has an average analyst price target of $47.50 versus $43.56.

Central Garden & Pet (CENTA) owns about 65 pet-care and lawn/garden brands, including Nylabone, Kaytee, Aqueon, Pennington and Amdro. In April 2026, it announced a joint venture with Phillips Pet Food & Supplies to spin out its pet distribution into a stand-alone platform, with Central retaining a 20% stake. In fiscal Q2 2026, it reported record net sales of $906M (vs. $833M), gross margin improvement, and operating income of $113.9M (vs. $93.3M), and reaffirmed full-year EPS guidance of $2.70+.

Central Garden & Pet (CENT) reported Q1 2026 revenue of US$617.4 million and basic EPS of US$0.11, with trailing twelve-month net profit margins reaching 5%. While recent profitability is strong, a 5-year EPS decline of 2.3% annually suggests a mixed long-term earnings record. Analysts project margin improvements to 6.1% and higher revenue growth, despite some bearish concerns about slower growth in core segments.

The Vanguard Group has filed an Amendment No. 14 to a Schedule 13G/A, reporting 0 shares of Central Garden & Pet Co Common Stock, representing 0% of the class. This change is due to an internal realignment effective January 12, 2026, where certain Vanguard subsidiaries will now report their holdings separately as per SEC Release No. 34-39538. Ashley Grim, Head of Global Fund Administration, signed the filing dated March 26, 2026.

Central Garden & Pet Company announced the appointment of Kay M. Schwichtenberg to its Board of Directors, effective March 1. Schwichtenberg brings over 40 years of experience in the animal health industry, including 29 years with Central, where she previously served as Executive Vice President, Animal & Public Health. The company anticipates her extensive leadership and operational expertise will contribute to growth, innovation, and long-term value creation.

Central Garden & Pet has acquired the U.S. assets of Champion USA, a livestock health company specializing in cattle fly control with its JustiFLY product line. This acquisition expands Central Garden & Pet's presence in the animal health sector, strengthening its position in the growing segment of livestock fly control solutions. Champion USA's employees will join Central's Professional business unit, with the transaction officially closing on December 12, 2025.

CENT posts a narrower Q4 loss as sales rise, gross margin expands and Garden strength offsets pressure in pet durables.